8-K: Presidio Property Trust Reports Q2 2024 Results with Increased Net Loss Despite Leasing Gains

Presidio Property Trust reported a net loss of $12.4 million for the second quarter of 2024, despite increased leasing activity and revenue.

Summary

• Presidio Property Trust announced its financial results for the quarter ended June 30, 2024, revealing a net loss of approximately $12.4 million, or ($1.00) per share, compared to a net loss of $1.8 million, or ($0.15) per share, for the same period in 2023.
• Total revenue for the quarter was $4.6 million, slightly up from $4.5 million in the prior year.
• The company's net real estate assets decreased to $130.9 million from $138.9 million year-over-year, with the average number of model homes held decreasing from 101 to 84.
• General and administrative expenses increased to $2.2 million, up from $1.8 million, primarily due to costs associated with the annual meeting and a settlement with Zuma Capital Management.
• A non-cash impairment charge of $0.1 million was recognized on three model homes due to a change in builder product style.
• The company sold 15 model homes for $7.4 million, realizing a net gain of $0.8 million.
• Presidio recorded a net loss of $10.0 million on its investment in Conduit Pharmaceuticals due to fair value adjustments.
• FFO decreased to $(1.3 million) from $(0.5 million) year-over-year, and Core FFO decreased to $(0.4 million) from $(0.2 million).
• The company acquired seven model homes for $3.5 million and renewed 78% of expiring square footage during the first and second quarters.
• The company entered into 10 new leases totaling nearly 36,000 square feet during the first and second quarters.

Sentiment

Score: 3

Explanation: The document presents a negative outlook due to a significant increase in net loss, decreased FFO and Core FFO, and a substantial loss on a key investment. While there are some positives in leasing activity, the overall financial performance is concerning.

Positives

• The company successfully renewed 78% of expiring square footage during the first and second quarters.
• The company entered into 10 new leases totaling nearly 36,000 square feet during the first and second quarters.
• The company sold 15 model homes for $7.4 million, resulting in a net gain of $0.8 million.
• Total revenue increased slightly to $4.6 million from $4.5 million year-over-year.

Negatives

• The company reported a net loss of $12.4 million for Q2 2024, a significant increase from the $1.8 million loss in Q2 2023.
• A $10.0 million net loss was recorded on the investment in Conduit Pharmaceuticals due to fair value adjustments.
• FFO decreased to $(1.3 million) from $(0.5 million) year-over-year.
• Core FFO decreased to $(0.4 million) from $(0.2 million) year-over-year.
• General and administrative expenses increased by $0.4 million due to the annual meeting and a settlement with Zuma Capital Management.
• A non-cash impairment charge of $0.1 million was recognized on three model homes.

Risks

• The company's financial performance is heavily impacted by changes in the fair value of its investment in Conduit Pharmaceuticals.
• The company is susceptible to changing market conditions in the geographic areas where its properties are located.
• The company's FFO and Core FFO are significantly down year-over-year.
• The company's G&A expenses have increased significantly due to one-off events.
• The company has a significant amount of mortgage debt outstanding.

Future Outlook

The company expects to record a net gain on model home sales in the third quarter of 2024.

Management Comments

• Our overall leasing outlook is positive said Gary Katz, the Company's Chief Investment Officer.

Industry Context

The results reflect the challenges faced by REITs in the current economic environment, including increased operating costs and market fluctuations. The company's focus on leasing activity and model home sales is consistent with strategies used by other REITs to manage their portfolios.

Comparison to Industry Standards

• Presidio's net loss of $12.4 million is significantly worse than the average performance of comparable REITs, which have generally reported modest profits or smaller losses.
• The decrease in FFO and Core FFO is also concerning, as many REITs have been able to maintain or slightly increase these metrics.
• The company's reliance on model home sales for revenue is a unique strategy compared to other REITs that focus on long-term leases.
• The significant loss on the Conduit Pharmaceuticals investment is unusual and highlights the risks of non-core investments for REITs.
• Compared to companies like American Tower (AMT) or Prologis (PLD), which are large-cap REITs with diversified portfolios, Presidio's performance is significantly weaker.

Stakeholder Impact

• Shareholders will be negatively impacted by the increased net loss and decreased FFO and Core FFO.
• Employees may be concerned about the company's financial performance and its potential impact on job security.
• Customers (tenants) may be impacted by any changes in the company's strategy or property management.
• Creditors may be concerned about the company's ability to repay its debts given the increased losses.

Next Steps

• The company expects to record a net gain on model home sales in the third quarter of 2024.
• The company will continue to manage its commercial and model home portfolios.

Key Dates

Keywords

REIT, Real Estate, Model Homes, Leasing, Net Loss, FFO, Core FFO, Impairment, Conduit Pharmaceuticals, Financial Results